profit from every $100 of sales.
$0$100
U.S. Physical Therapy
$100.10+0.87% today
+34.6% in 1 year
1-year low $59.001-year high $100.10
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $99.21 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What U.S. Physical Therapy sold, what it kept, and what it did with the cash.
Sales went from $553 million in 2022 to $781 million in 2025, with $15.1 million of profit last year.
SalesProfit
U.S. Physical Therapy handed back 54% of the cash it generated last year.
$27M
Free cash flow 2025$61M
Bought back its own shares$6M
Paid as dividends$27M
Cash vs. debt$36M vs. $315M
U.S. Physical Therapy vs. similar companies
U.S. Physical Therapy grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| U.S. Physical Therapy | 99.2× · Very expensive | ||
 HCA Healthcare | 15.6× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.5× · Fair price | ||
 IHH Healthcare Berhad | 33.4× · Expensive | ||
 Rede D'Or São Luiz | 15.9× · Fair price |
AI analysis
An AI analyst reads U.S. Physical Therapy's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 553 | 605 | 671 | 781 | |
| 112 | 122 | 124 | 150 | |
| 66 | 70 | 66 | 80 | |
| 76 | 74 | 87 | 110 | |
| 28 | 15 | 26 | 15 | |
| 2.25 | 1.28 | 1.84 | 1.42 | |
| 20.3% | 20.1% | 18.5% | 19.2% | |
| 11.9% | 11.6% | 9.8% | 10.3% | |
| 5.1% | 2.4% | 3.9% | 1.9% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 858 | 997 | 1,167 | 1,204 |
| Cash | 32 | 153 | 41 | 36 |
| Total debt | 295 | 259 | 295 | 315 |
| Total liabilities | 374 | 345 | 408 | 434 |
| 316 | 476 | 489 | 476 | |
| 13 | 14 | 15 | 15 | |
| 7.9% | 6.3% | 6.9% | 8.7% | |
| 9.0% | 3.1% | 5.4% | 3.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 59 | 82 | 75 | 75 | |
| 8 | 9 | 9 | 14 | |
| 50 | 73 | 66 | 61 | |
| Dividends paid | 21 | 24 | 27 | 27 |
| – | 0 | 0 | 6 | |
| 7 | 7 | 8 | 8 |
Valuation
- 99.2×
- 35.0×
- –
- 2.7×
- 1.9×
- 24.5×
- 16.2×
- 4.1%
- 1.0%
- 3.0%
Profitability
- 19.2%
- 10.3%
- 1.9%
- 14.4%
- 8.9%
- 7.6%
- 0.2%
- 0.1%
- 7.8%
- –
Growth
- +12.2%
- −14.2%
- −7.2%
- +41.3%
- +5.3%
Financial health
- 2.5×
- 0.66
- 29.2%
- 9.2×
- 1.01
- 1.19
- 0.59
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 34%of 958
Top 47%of 888
Bottom 9%of 600
Top 45%of 889
Top 28%of 987
What analysts expect
- Average price target
- $102.00
- Range
- $102.00 – $102.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | 0.46 | 0.55 | −16.4% |
| Feb 25, 2026 | 0.67 | 0.67 | +0.0% |
| Nov 5, 2025 | 0.66 | 0.67 | −1.5% |
| Aug 6, 2025 | 0.81 | 0.71 | +14.1% |
| May 7, 2025 | 0.48 | 0.46 | +4.3% |
| Feb 26, 2025 | 0.65 | 0.69 | −5.8% |
| Nov 5, 2024 | 0.69 | 0.68 | +1.5% |
| Aug 13, 2024 | 0.73 | 0.81 | −9.9% |
3.0%of the share price, paid each year
On $1,000 invested$30a year at today's yield, before tax
+41.3%2020 to 2025
Raised5 yearsin a row, in our data
Paid per share, each year
$0.60 in 2015 → $1.80 in 2025
How safe it looks
181.7% of its profit
Room to growStretchedMore than it earns: 44.9%
News
Physical AI Empowers Smart Mobility: LUXEED Builds a New Full-Scenario Intelligent EcosystemYahoo Finance · Nov 6, 2026THE KOREA INDUSTRY DAILY: ROBOTWORLD 2026 to Spotlight Physical AI and AI-Driven Manufacturing With 402 Exhibitors From 17 CountriesYahoo Finance · Nov 4, 2026Accenture (ACN) Launches Physical AI Safety Suite For Factories And WarehousesYahoo Finance · Oct 27, 2026CoreWeave Vs. Nvidia: Demand For Silicon is Not The Same Thing as Solvent, Credit-Backed Demand for Physical InfrastructureYahoo Finance · Oct 27, 2026CORRECTING and REPLACING Waymo, Google and Microsoft Alums Raise $30M to Build the Data Layer for Physical AIYahoo Finance · Oct 26, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
28No pass
Benjamin Graham
33No pass
Philip Fisher
12No pass
Peter Lynch
28No pass
Joel Greenblatt
20No pass
Charlie Munger
6No pass
Terry Smith
14No pass
Questions about U.S. Physical Therapy
Is U.S. Physical Therapy a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the U.S. Physical Therapy AI analysis
What does U.S. Physical Therapy do?
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It is in Medical Care Facilities.
Does U.S. Physical Therapy pay a dividend?
Yes. At today's price the dividend is 3.0% a year, about 182% of its yearly profit. In 2025 it paid out $27.4 million in dividends.
Is U.S. Physical Therapy stock halal?
Yes. U.S. Physical Therapy passes our halal screen: its business is permitted and its debt is 21% of its market value, under the 30% limit. How we check
How has U.S. Physical Therapy stock done over the past year?
Up 34.6% over the past twelve months, to $100.10. It traded between $59.00 and $100.10, close to its high.
Who are U.S. Physical Therapy's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with U.S. Physical Therapy's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.